Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Sun Pharma Q2 net up over two-fold to Rs 2,235.14 cr

      Sun Pharma Q2 net up over two-fold to Rs 2,235.14 cr

      supriya kashyap kashyap11 Nov 2016 2:28 PM IST
      New Delhi : Drug major Sun Pharmaceutical Industries reported an over two-fold jump in its consolidated net profit to Rs 2,235.14 crore for the...
      All you need to know about Samsung

      All you need to know about Samsung's biotech unit in Seoul

      supriya kashyap kashyap11 Nov 2016 2:26 PM IST
      Seoul : Samsung Biologics Co., the contract drug making unit of Samsung Group, made its market debut in Seoul in South Korea's largest initial public...
      MannKind and Sanofi Reach Agreement on AFREZZA

      MannKind and Sanofi Reach Agreement on AFREZZA

      supriya kashyap kashyap11 Nov 2016 2:14 PM IST
      MannKind Corporation announced that MannKind and Sanofi have entered into an agreement with the following terms: The promissory note and security...
      Rs 64 crore fine on GlaxosmithKline, Sanofi: Compat overrules CCI orders

      Rs 64 crore fine on GlaxosmithKline, Sanofi: Compat overrules CCI orders

      supriya kashyap kashyap10 Nov 2016 1:35 PM IST
      New Delhi: Competition Appellate Tribunal set aside penalties totalling Rs 64 crore imposed by CCI on drug makers GlaxoSmithKline Pharmaceuticals and...
      Exclusive: Pfizer weighs sale or spin off of consumer health unit - sources

      Exclusive: Pfizer weighs sale or spin off of consumer health unit - sources

      supriya kashyap kashyap10 Nov 2016 1:32 PM IST
      n" style="transform: translate3d(0px, 0px, 0px);"U.S. drugmaker Pfizer Inc is evaluating a potential sale or spin-off of its consumer health division...
      Novartis, Pfizer cut prices to win UK approval for cancer drugs

      Novartis, Pfizer cut prices to win UK approval for cancer drugs

      supriya kashyap kashyap10 Nov 2016 1:30 PM IST
      London : Novartis and Pfizer have won approval for two cancer drugs to be used routinely on Britain's National Health Service after offering bigger...
      JnJ vaccine plus Gilead immune booster shows promise as HIV fighter

      JnJ vaccine plus Gilead immune booster shows promise as HIV fighter

      supriya kashyap kashyap10 Nov 2016 1:29 PM IST
      An experimental HIV vaccine from Johnson & Johnson combined with an immune system booster from Gilead Sciences Inc showed promise at keeping the...
      Pfizer says closing two British sites, not Brexit-related

      Pfizer says closing two British sites, not Brexit-related

      supriya kashyap kashyap10 Nov 2016 1:28 PM IST
      London : U.S. drugs company Pfizer said it was closing two sites in Britain that employ a total of 370 people following a review of its global supply...
      Pfizer net profit rises 52 percent in July-September

      Pfizer net profit rises 52 percent in July-September

      supriya kashyap kashyap9 Nov 2016 11:37 AM IST
      Kolkata : Pharmaceuticals major Pfizer Limited reported a 52 per cent rise in its net profit to Rs 126 crore in the three months ended on September...
      Mylan and Biocon Announce USFDA Submission for Proposed Biosimilar Trastuzumab

      Mylan and Biocon Announce USFDA Submission for Proposed Biosimilar Trastuzumab

      supriya kashyap kashyap9 Nov 2016 11:28 AM IST
      Bengaluru : Mylan N.V. and Biocon Ltd. announced submission of Mylan's biologics license application (BLA) for MYL-1401O, a proposed biosimilar...
      Quality concern in herbal medicine remains a challenge: AYUSH Minister

      Quality concern in herbal medicine remains a challenge: AYUSH Minister

      supriya kashyap kashyap9 Nov 2016 11:07 AM IST
      New Delhi : Traditional medicines have complex formulation which can't be explained through conventional parameters, AYUSH Minister Shripad Yesso Naik...
      Lupin receives EIR report from USFDA for Goa plant

      Lupin receives EIR report from USFDA for Goa plant

      supriya kashyap kashyap9 Nov 2016 11:02 AM IST
      New Delhi : Drug major Lupin today said it has received Establishment Inspection Report (EIR) from the US health regulator for its Goa plant leading...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok